1 |
MARAZITA M L, PLOUGHMAN L M, RAWLINGS B, et al. Genetic epidemiological studies of early-onset deafness in the US school-age population[J]. Am J Med Genet, 1993, 46(5): 486-491.
|
2 |
MORTON C C, NANCE W E. Newborn hearing screening: a silent revolution[J]. N Engl J Med, 2006, 354(20): 2151-2164.
|
3 |
KELSELL D P, DUNLOP J, STEVENS H P, et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness[J]. Nature, 1997, 387(6628): 80-83.
|
4 |
KELLEY P M, HARRIS D J, COMER B C, et al. Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss[J]. Am J Hum Genet, 1998, 62(4): 792-799.
|
5 |
JAGGER D J, FORGE A. Connexins and gap junctions in the inner ear: it's not just about K+ recycling[J]. Cell Tissue Res, 2015, 360(3): 633-644.
|
6 |
SANTOS-SACCHI J, DALLOS P. Intercellular communication in the supporting cells of the organ of Corti[J]. Hear Res, 1983, 9(3): 317-326.
|
7 |
KIKUCHI T, KIMURA R S, PAUL D L, et al. Gap junctions in the rat cochlea: immunohistochemical and ultrastructural analysis[J]. Anat Embryol (Berl), 1995, 191(2): 101-118.
|
8 |
WANG Y F, CHANG Q, TANG W X, et al. Targeted connexin26 ablation arrests postnatal development of the organ of Corti[J]. Biochem Biophys Res Commun, 2009, 385(1): 33-37.
|
9 |
MEI L, CHEN J, ZONG L, et al. A deafness mechanism of digenic Cx26 (GJB2) and Cx30 (GJB6) mutations: reduction of endocochlear potential by impairment of heterogeneous gap junctional function in the cochlear lateral wall[J]. Neurobiol Dis, 2017, 108: 195-203.
|
10 |
AKIL O, SEAL R P, BURKE K, et al. Restoration of hearing in the Vglut3 knockout mouse using virally mediated gene therapy[J]. Neuron, 2012, 75(2): 283-293.
|
11 |
ASKEW C, ROCHAT C, PAN B F, et al. Tmc gene therapy restores auditory function in deaf mice[J]. Sci Transl Med, 2015, 7(295): 295ra108.
|
12 |
GYÖRGY B, MEIJER E J, IVANCHENKO M V, et al. Gene transfer with AAV9-PHP.B rescues hearing in a mouse model of usher syndrome 3A and transduces hair cells in a non-human primate[J]. Mol Ther Methods Clin Dev, 2018, 13: 1-13.
|
13 |
YU Q, WANG Y, CHANG Q, et al. Virally expressed connexin26 restores gap junction function in the cochlea of conditional Gjb2 knockout mice[J]. Gene Ther, 2014, 21(1): 71-80.
|
14 |
IIZUKA T, KAMIYA K, GOTOH S, et al. Perinatal Gjb2 gene transfer rescues hearing in a mouse model of hereditary deafness[J]. Hum Mol Genet, 2015, 24(13): 3651-3661.
|
15 |
CHEN Y, HU L X, WANG X L, et al. Characterization of a knock-in mouse model of the homozygous p.V37I variant in Gjb2[J]. Sci Rep, 2016, 6: 33279.
|
16 |
YUAN Y Y, YOU Y W, HUANG D L, et al. Comprehensive molecular etiology analysis of nonsyndromic hearing impairment from typical areas in China[J]. J Transl Med, 2009, 7: 79.
|
17 |
LI L, LU J R, TAO Z, et al. The p.V37I exclusive genotype of GJB2: a genetic risk-indicator of postnatal permanent childhood hearing impairment[J]. PLoS One, 2012, 7(5): e36621.
|
18 |
LIN X, LI G, ZHANG Y, et al. Hearing consequences in Gjb2 knock-in mice: implications for human p.V37I mutation[J]. Aging, 2019, 11(18): 7416-7441.
|
19 |
TAKADA Y, BEYER L A, SWIDERSKI D L, et al. Connexin 26 null mice exhibit spiral ganglion degeneration that can be blocked by BDNF gene therapy[J]. Hear Res, 2014, 309: 124-135.
|
20 |
HUANG S S, HUANG B Q, WANG G J, et al. The relationship between the p.V37I mutation in GJB2 and hearing phenotypes in Chinese individuals[J]. PloS One, 2015, 10(6): e0129662.
|
21 |
GUO J Y, MA X B, SKIDMORE J M, et al. GJB2 gene therapy and conditional deletion reveal developmental stage-dependent effects on inner ear structure and function[J]. Mol Ther Methods Clin Dev, 2021, 23: 319-333.
|
22 |
KANG W, ZHAO X L, SUN Z E, et al. Adeno-associated virus vector enables safe and efficient Cas9 activation in neonatal and adult Cas9 knockin murine cochleae[J]. Gene Ther, 2020, 27(7/8): 392-405.
|
23 |
ZHAO X L, JIN C X, DONG T T, et al. Characterization of promoters for adeno-associated virus mediated efficient Cas9 activation in adult Cas9 knock-in murine cochleae[J]. Hear Res, 2020, 394: 107999.
|
24 |
LI C W, SAMULSKI R J. Engineering adeno-associated virus vectors for gene therapy[J]. Nat Rev Genet, 2020, 21(4): 255-272.
|
25 |
DING D L, LIU H, QI W D, et al. Ototoxic effects and mechanisms of loop diuretics[J]. J Otol, 2016, 11(4): 145-156.
|